Our Mission: Cure Desmoid Tumors
The Desmoid Tumor Research Foundation (DTRF) empowers and unites everyone committed to finding answers for the desmoid tumor community. We aggressively fund desmoid tumor research, accelerate the development of improved therapies, drive collaborations among clinicians and researchers worldwide, and support patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Learn more about submitting a grant proposal.
EXPLORE THE RESEARCH WE’VE FUNDED AT PRESTIGIOUS INSTITUTIONS AROUND THE WORLD.
| Year | Principal Investigator | Award Title | |
|---|---|---|---|
| Year2017 | Principal InvestigatorDaniela Segat, PhD, ''Mauro Baschirotto'' Institute for Rare Diseases - B.I.R.D. Foundation, Italy | Award Title“In vitro study of the involvement of cell-cell and cell-matrix and focal adhesion formation in desmoid-type fibromatosis myofibroblastic differentiation under pro-inflammatory stimuli.” Year 1 of 1 | View Project |
| Year2017 | Principal InvestigatorRaphael E. Pollock, MD, PhD, The Ohio State University | Award Title“Reactivating apoptosis: a potential therapeutic target for desmoid tumors with CTNNB1 S45F mutation.” Year 3 of 3 | View Project |
| Year2017 | Principal InvestigatorYoshihiro Nishida, MD, PhD, Nagoya University Graduate School of Medicine | Award Title“Effects of mechanical forces on the cell and tumor behavior of desmoid-type fibromatosis.” Year 1 of 1 | View Project |
| Year2017 | Principal InvestigatorBenjamin Alman, MD, Duke University, with collaborators Robert Maki, MD, PhD, Mt. Sinai Medical Center; Alexander Lazar, MD Anderson Cancer Center; Alessandro Datti, PhD, Samuel Lunenfeld Research Institute | Award Title“Collaboration for a cure: identifying new therapeutic targets for desmoid tumors.” Year 5 | View Project |
| Year2017 | Principal InvestigatorBenjamin Alman, MD, and Mushriq Al-Jazrawe, HBSc, PhD Candidate, The Hospital for Sick Children, Toronto, Ontario, Canada | Award Title“Single cell-derived clonal analysis of desmoid tumors to investigate tumor-stroma interactions.” Year 2 of 3. | View Project |
| Year2016 | Principal InvestigatorBreelyn Wilky, MD, Sylvester Comprehensive Cancer Center University of Miami | Award Title“Correlation of CTNNB1 mutation status with chemotherapy response by MRI in patients with desmoid tumors.” Year 1 of 2 | View Project |
| Year2016 | Principal InvestigatorKris Vleminckx, PhD, Ghent University, Belgium | Award Title“Identifying targets for therapy in a novel genetic Xenopus model for desmoid tumor formation.” Year 1 of 3 | View Project |
| Year2016 | Principal InvestigatorRaphael E. Pollock, MD, PhD, Ohio State University | Award Title“Reactivation of apoptosis: a potential therapeutic target for desmoid tumors with CTNNB1 S45F mutation.” Year 2 of 3 | View Project |
| Year2016 | Principal InvestigatorKelly Mercier, PhD, RTI International | Award Title“A metabolomics pilot study on desmoid tumors and novel drug candidates.” Year 1 of 1 | View Project |
| Year2016 | Principal InvestigatorShivaani Kummar, MD, FACP, Stanford University, USA in collaboration with Jaw-Town Lin, MD, PhD, Fu Jen University, Taiwan | Award Title“Desmoid tumors for big data linkage.” Year 1 of 1 | View Project |
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.
